Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis135
Challenges in preserving antibiotic effectiveness: time for a novel approach90
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex66
Neonatal ocular prophylaxis in the United States: is it still necessary?57
Visceral leishmaniasis elimination in India: progress and the road ahead53
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future48
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review45
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin43
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies38
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia38
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a38
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72038
The global surge of drug-resistant infections and what it reveals about our failing defenses37
A multicenter study of antibiotic resistance patterns of bacterial isolates from patients with hematological and solid cancers37
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies36
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines35
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?34
Difficile to treat: advanced management strategies in difficult to treat Clostridioides difficile infections34
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?32
Can Saccharomyces cerevisiae be used as a therapeutic agent for vulvovaginal candidiasis?29
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis28
Treatment of vaginitis caused by non-albicans Candida species27
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges27
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections27
Identifying predictors of treatment failure with community-acquired pneumonia: an update26
Reemergence of monkeypox: prevention and management25
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis25
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China24
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective23
Treatment of pulmonary mucormycosis: current concepts23
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections22
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?21
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin21
Advances in therapeutic strategies against Mycobacterium marinum infection21
Diagnostic and clinical management of Candida auris infections in immunocompromised patients20
Impact of a clinical engagement targeted antimicrobial stewardship program on antimicrobial use in Pakistan: a multicenter longitudinal point prevalence survey20
Infliximab as a potential treatment for COVID-1920
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline20
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures20
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases19
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges19
Diagnostic and management strategies for chronic hepatitis E infection19
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-1919
One health and resistant fungi: a challenging balancing act between food security and patient survival18
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance17
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta17
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases17
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges16
Correction16
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)16
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies16
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development16
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury16
Statement of Retraction16
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae15
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections15
The serological dilemma: rethinking syphilis treatment evaluation15
Risk of HIV viral rebound after SARS-CoV-2 infection among people living with HIV on antiretroviral therapy: a retrospective matched cohort study15
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana15
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential15
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae14
Diagnosing fungal infections in clinical practice: a narrative review14
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches14
Inhibiting horizontal gene transfer to contain antimicrobial resistance: conjugation and plasmid maintenance as druggable targets14
Monoclonal antibodies for the treatment of COVID-19 infection in children13
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India13
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study13
The evolving debate around screening for Chlamydia trachomatis13
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas13
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat13
How can we tackle the overuse of antibiotics in low- and middle-income countries?12
Challenges associated with pertussis detection, monitoring, and vaccination in adults12
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection12
Disruptive innovation in antibiotic development: a vision for lysins12
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations12
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision12
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?12
Precision antibiotic treatment in intensive care unit-acquired lower respiratory tract infections (ICU-LRTIs): contemporary concepts and future directions12
Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority12
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae12
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review12
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea12
How do we best manage Clostridioides difficle infections in the elderly?11
Gram-positive infections in special populations. Expert view on the role of dalbavancin11
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis11
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers11
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents11
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials11
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America11
Tocilizumab for the treatment of COVID-1911
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals11
Unmet targets: evaluating vancomycin use and predictive factors of target attainment in hemodialysis patients11
A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China11
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review11
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?10
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients10
Comparative effectiveness of ceftaroline plus vancomycin or daptomycin versus vancomycin or daptomycin monotherapy for MRSA bacteremia: an updated systematic review and meta-analysis10
Now that griseofulvin is not available, what to do with tinea capitis treatments?10
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials10
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-1910
New insights into the treatment of acute otitis media10
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients10
Diagnosis of urinary tract infections in the pediatric population – current practices, advances and progress10
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance9
Efficacy and safety of gepotidacin versus standard of-care antibiotics for the treatment of uncomplicated urogenital infections in adults and adolescents: a systematic review and meta-analysis9
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan9
Global importance of new treatment strategies to efforts to control hepatitis B virus9
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t9
The effect of combination antibiotic therapy on mortality in patients with sepsis or septic shock due to Pseudomonas aeruginosa bloodstream infections: a9
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo9
Artificial intelligence and prescription of antibiotic therapy: present and future9
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects9
An update on newer antifungals9
1.1245868206024